The Cleveland Clinic: Diabetes Mellitus, Type 2 trials
The registry lists 12 Diabetes Mellitus, Type 2 studies with The Cleveland Clinic as lead sponsor. 1 are open to participants now and 5 have results posted.
Phase 4 4No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Imaging in Semaglutide StudyRecruitingNCT07695454
- Holding vs. Continuing Incretin-based Therapies Before Upper EndoscopyCompletedNCT06533527Phase 4Results posted
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2DCompletedNCT04538352Phase 4Results posted
- EMI-EHP Weight Management and Type 2 Diabetes Pragmatic TrialTerminatedNCT04531176Phase 4Results posted
- CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 DiabetesTerminatedNCT02912455Phase 4Results posted
- Advanced Medical Therapy Versus Advanced Medical Therapy Plus Bariatric Surgery for the Resolution of Type 2 DiabetesCompletedNCT00432809Not applicableResults posted
- Glycemic Control, Type II Diabetes, ParathyroidectomyActive, not recruitingNCT05761743
- The Prevalence of Autoimmune Antibodies in Patients with Type 2 Diabetes Managed by Endocrinology Vs. Primary CareCompletedNCT05553145
- Randomized Controlled Trial of Digital Twin Precision Treatment: A Novel Whole Body Digital Twin Enabled Precision Treatment for Type 2 DiabetesActive, not recruitingNCT05181449Not applicable
- Bariatric Surgery-Induced Shift in Gut Microbiome and NAFLDCompletedNCT04263376
- Effect of Bariatric Surgery on Mechanisms of Type 2 DiabetesCompletedNCT01278823Not applicable
- Diabetes Mellitus Type II and Tissue OxygenationTerminatedNCT00554697